Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that AgeneBio hired Dr. Richard Mohs as vice president of clinical development. Most recently, he worked at Eli Lilly, where he was vice president for neuroscience early clinical development, where he led a clinical development team targeting Alzheimer’s disease and other neurodegenerative diseases.

CoLucid Pharmaceuticals hired Raymond Skwierczynski as head of pharmaceutical operations;


Agios Pharmaceuticals said John Duncan Higgons is resigning as chief operating officer;

Caligor Rx hired Michael Dallmann as director of strategic planning;


Syros Pharmaceuticals hired Dr. David Roth as chief medical officer;

Pulmatrix named Mark Iwicki as board chairman;

Scilex Pharmaceuticals hired Dean Ferrigno as vice president of finance;

Scilex Pharmaceuticals hired Kip Vought as vice president of development;

Sprout Pharmaceuticals said Chief Executive Cindy Whitehead will be leaving;

Symic Biomedical hired Seema Kantak as chief scientific officer;

The Medicines Company said President and Chief Financial Officer Glenn Sblendorio will retire;

The Medicines Company said William O’Connor will be promoted to chief financial officer;

Biothera Pharmaceutical hired Barry Labinger as chief executive officer;

Ignyta hired William McCarthy as chief business officer.